Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Bordron

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Marine Drugs|November 14, 2008
Floridoside extracted from the red alga Mastocarpus stellatus is a potent activator of the classical complement pathwayAnthony Courtois, Christelle Simon-Colin, Claire Boisset, et al.
Advances in Experimental Medicine and Biology|May 24, 2020
Epigenetics in Primary Sjögren's SyndromeAnne Bordron, Valérie Devauchelle-Pensec, Christelle Le Dantec, et al.
Frontiers in Immunology|December 24, 2019
JAK Inhibitors and Oxidative Stress ControlAmandine Charras, Pinelopi Arvaniti, Christelle Le Dantec, et al.
Cancer Research|September 17, 2008
Purine-rich box-1-mediated reduced expression of CD20 alters rituximab-induced lysis of chronic lymphocytic leukemia B cellsAmani Mankaï, Anne Bordron, Yves Renaudineau, et al.
Leukemia Research|May 18, 2005
Establishment of a novel human B-CLL-like xenograft model in nude mouseSeverine Loisel, Karine Le Ster, Isabelle Quintin-Roue, et al.
Frontiers in Immunology|September 18, 2015
An in silico Approach Reveals Associations between Genetic and Epigenetic Factors within Regulatory Elements in B Cells from Primary Sjögren's Syndrome PatientsOrsia D Konsta, Christelle Le Dantec, Amandine Charras, et al.
International Journal of Molecular Sciences|April 3, 2021
Hyposialylation Must Be Considered to Develop Future Therapies in Autoimmune DiseasesAnne Bordron, Marie Morel, Cristina Bagacean, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patientsSteven Nédellec, Yves Renaudineau, Anne Bordron, et al.
Annals of the New York Academy of Sciences|September 7, 2007
Is the c-Cbl proto-oncogene involved in chronic lymphocytic leukemia?Amani Mankaï, Jean-Richard Eveillard, Virginie Buhé, et al.
Journal of Neuro-Oncology|June 16, 2007
Low HER2-expressing glioblastomas are more often secondary to anaplastic transformation of low-grade gliomaJean-François Mineo, Anne Bordron, Marc Baroncini, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Marine Drugs|November 14, 2008
Floridoside extracted from the red alga Mastocarpus stellatus is a potent activator of the classical complement pathwayAnthony Courtois, Christelle Simon-Colin, Claire Boisset, et al.
Advances in Experimental Medicine and Biology|May 24, 2020
Epigenetics in Primary Sjögren's SyndromeAnne Bordron, Valérie Devauchelle-Pensec, Christelle Le Dantec, et al.
Frontiers in Immunology|December 24, 2019
JAK Inhibitors and Oxidative Stress ControlAmandine Charras, Pinelopi Arvaniti, Christelle Le Dantec, et al.
Cancer Research|September 17, 2008
Purine-rich box-1-mediated reduced expression of CD20 alters rituximab-induced lysis of chronic lymphocytic leukemia B cellsAmani Mankaï, Anne Bordron, Yves Renaudineau, et al.
Leukemia Research|May 18, 2005
Establishment of a novel human B-CLL-like xenograft model in nude mouseSeverine Loisel, Karine Le Ster, Isabelle Quintin-Roue, et al.
Frontiers in Immunology|September 18, 2015
An in silico Approach Reveals Associations between Genetic and Epigenetic Factors within Regulatory Elements in B Cells from Primary Sjögren's Syndrome PatientsOrsia D Konsta, Christelle Le Dantec, Amandine Charras, et al.
International Journal of Molecular Sciences|April 3, 2021
Hyposialylation Must Be Considered to Develop Future Therapies in Autoimmune DiseasesAnne Bordron, Marie Morel, Cristina Bagacean, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patientsSteven Nédellec, Yves Renaudineau, Anne Bordron, et al.
Annals of the New York Academy of Sciences|September 7, 2007
Is the c-Cbl proto-oncogene involved in chronic lymphocytic leukemia?Amani Mankaï, Jean-Richard Eveillard, Virginie Buhé, et al.
Journal of Neuro-Oncology|June 16, 2007
Low HER2-expressing glioblastomas are more often secondary to anaplastic transformation of low-grade gliomaJean-François Mineo, Anne Bordron, Marc Baroncini, et al.
Pageof 4